Expert Interview
Discussing the results from the Phase 2 Study of Vertex' suzetrigine for the treatment of painful lumbosacral radiculopathy
Ticker(s): VRTXInstitution: Vanderbilt University
- Interventional pain medicine physician at Vanderbilt University Medical Center
- Co-director of the Vanderbilt Center for Neuromodulation who manages 100+ patients for pain
- Special interest in spinal stimulators and other alternative approaches for pain management
Can you please give us some background on your clinical practice and how many patients you manage pain for?
Added By: ben_adminWhat is your current standard of care for managing pain in your settings?
Added By: ben_adminCan you discuss the need for alternatives to opioids for pain management?
Added By: ben_adminWhat are your thoughts on the potential of Suzetrigine from Vertex?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
